Custom Search

Promethazine News

No More Than Necessary: Safety and Efficacy of Low-Dose Promethazine

BACKGROUND: Limitations in antiemetic options have resulted in increased use of intravenous promethazine. However, this drug has significant sedative effects with its standard dosage of 25 mg, especially when used in conjunction...

The human Ca2+-activated K+ channel, IK, can be blocked by the tricyclic antihistamine promethazine

Phenothiazines can be used as psychopharmaceutical agents and are known to cause many side effects during treatment since they interfere with many different cellular systems.

Cadila gets US FDA approval for Promethazine tablets

Cadila Healthcare Ltd on Monday said that it has received US Food Drug Administration (US FDA) approval to market Promethazine tablets 12.5 mg, 25 mg and 50 mg in the US.

Compounds from NINDS FDA Approved Drug Screening Program

Dr. Lucie Bruijn of the Amyotrophic Lateral Sclerosis Association presented results of a study of Ceftriaxone in the ALS mouse. Ceftriaxone, a drug selected for its assessment on a battery of ALS-relevant assays, was administered...

FDA Safety Labeling Changes: Bextra, Phenergan, Cosmegen

The U.S. Food and Drug Administration (FDA) approved in November 2004 revisions to safety labeling to advise healthcare professionals of the following changes: valdecoxib use is contraindicated for pain management immediately...

Displaying results 16 to 20 out of 23

< Previous

1

2

3

4

5

Next >

Use of this site is subject to the following terms of use